Operose Advisors’s Criteo S.A. CRTO Stock Holding History

Operose Advisors’s Portfolio CRTO Stock Details CRTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-208	Closed	-$8.37K	–	476
2024 Q3	$8.37K	Hold	208	–	–	﹤0.01%	511
2024 Q2	$7.85K	Hold	208	–	–	﹤0.01%	471
2024 Q1	$7.29K	Hold	208	–	–	﹤0.01%	516
2023 Q4	$5.27K	Hold	208	–	–	﹤0.01%	524
2023 Q3	$6.07K	Buy	+208	New	+$6.38K	﹤0.01%	639

Other funds holding CRTO

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Operose Advisors's CRTO Position: Q4 2024 in Review

Operose Advisors sold out of Criteo S.A. (CRTO) in Q4 2024, closing a stake of 208 shares — an estimated $8.37K sold.

Operose Advisors first reported a position in CRTO in Q3 2023 and held it in 5 quarters. The position peaked at $8.37K in Q3 2024. 180 funds tracked by Wall St. Rank hold CRTO as of Q4 2024.

Operose Advisors reported no remaining Criteo S.A. position as of Q4 2024 after selling out during the quarter.
Operose Advisors sold 208 Criteo S.A. shares in Q4 2024, an estimated $8.37K.
Operose Advisors first reported a position in Criteo S.A. in Q3 2023 and held it in 5 quarters.
Operose Advisors's Criteo S.A. position peaked at $8.37K in Q3 2024.
180 funds tracked by Wall St. Rank held Criteo S.A. as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.